OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

To reveal more filter options, please select whether you would like to review Active or Closed projects:

Clear
Organization: Amylyx Pharmaceuticals, Inc.

1 Projects | 1 Researchers | $928,234 Invested

2017

Amylyx Pharmaceuticals, Inc.

Kent Leslie

Phase II Study to Assess Safety and Target Engagement in AMYX0035 in AD

  • Funding Amount: $928,234
  • Organization Type: Biotechnology/For Profit
  • Program: Clinical
  • Target: Epigenetics
  • Status: Closed